Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if LPCN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
8 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 13 days ago
Red flags: 1
36 filers reported a long position in LPCN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Squadron Capital Management LLC | $2.1M | 810K | +80% |
| Ikarian Capital, LLC | $1.3M | 508.6K | Unchanged |
| Eversept Partners, LP | $755.2K | 295K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $590.9K | 230.8K | +15% |
| ACADIAN ASSET MANAGEMENT LLC | $435K | 170.4K | New |
| BOOTHBAY FUND MANAGEMENT, LLC | $359.6K | 140.5K | Unchanged |
| JANE STREET GROUP, LLC | $243.8K | 95.2K | +375.5% |
| BlackRock, Inc. | $228.5K | 89.3K | Unchanged |
| TWO SIGMA INVESTMENTS, LP | $217.3K | 84.9K | +151.5% |
| CITADEL ADVISORS LLC | $207.9K | 81.2K | +179.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.